ISS Recommends Shareholders Reject CoreWeave’s $9 Billion Acquisition Deal

CoreWeave CEO Michael Intrator insists the $9 billion offer is fair, while ISS urges rejection of the deal, citing Core Scientific's ability to grow independently.

BTC

Summary

CoreWeave CEO Michael Intrator confirmed the company will not raise its $9 billion all-stock offer for Core Scientific (CORZ), calling it a ‘nice to have, not a need to have.’ Proxy advisory firm ISS has recommended shareholders reject the deal, arguing Core Scientific can continue to grow independently. CoreWeave’s stock has dropped 4.3% following the announcement, while Core Scientific’s stock rose 1.6%, indicating market preference for the company’s independence.

Terms & Concepts
  • Proxy Advisory Firm: An organization that provides voting recommendations and corporate governance research to institutional investors for shareholder meetings.
  • Acquisition Deal: A transaction in which one company purchases another, gaining control of its operations and assets.
  • Shareholder Vote: A formal decision-making process where investors cast votes on corporate proposals, mergers, or governance matters.